03829nam a22005415i 4500 978-3-031-53659-5 DE-He213 20251030112000.0 cr nn 008mamaa 240418s2024 sz | s |||| 0|eng d 9783031536595 978-3-031-53659-5 10.1007/978-3-031-53659-5 doi RC666-701.2 MJD bicssc MED010000 bisacsh MJD thema Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation [electronic resource] / edited by Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh. 1st ed. 2024. Cham : Springer Nature Switzerland : Imprint: Springer, 2024. VI, 291 p. 37 illus., 34 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda HSCT at a glance -- Burden of cardiovascular disease in HSCT -- Risk factors and Mechanisms of Cardiotoxicity in HSCT -- Cardiotoxicity of commonly used drugs in HSCT -- Pre-HSCT cardiovascular evaluation -- HSCT in low EF patients -- Arrhythmias and conduction disorders in HSCT -- Coronary and peripheral arterial disease in HSCT -- Thrombotic disease in HSCT -- Pulmonary hypertension in HSCT -- Pericardial disease in HSCT -- Metabolic syndrome in HSCT -- HSCT in patients with cardiac amyloidosis -- HSCT in patients with autoimmune conditions, sickle cell anaemia and thalassemia -- Cardiotoxicity surveillance and cardioprotective strategies in HSCT. This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology. Cardiology. 75410 Cancer Genetic aspects. 73501 Cardiology. 75410 Cancer Genetics and Genomics. 73502 Alizadehasl, Azin. editor. edt http://id.loc.gov/vocabulary/relators/edt 75411 Ghavamzadeh, Ardeshir. editor. edt http://id.loc.gov/vocabulary/relators/edt 75412 Emami, Amir Hossein. editor. edt http://id.loc.gov/vocabulary/relators/edt 75413 Janbabaei, Ghasem. editor. edt http://id.loc.gov/vocabulary/relators/edt 75414 Khoda-Amorzideh, Davood. editor. edt http://id.loc.gov/vocabulary/relators/edt 75415 SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031536588 Printed edition: 9783031536601 Printed edition: 9783031536618 https://doi.org/10.1007/978-3-031-53659-5 ZDB-2-SME ZDB-2-SXM 59228 59228